• 1. Evolution of calcium phosphate precipitation in hanging drop vapor diffusion by in situRaman microspectroscopy
  Gloria Belén Ramírez-Rodríguez,José Manuel Delgado-López,Jaime Gómez-Morales CrystEngComm, 2013,15, 2206-2212
• 2. Emerging investigator series: heterogeneous reactions of sulfur dioxide on mineral dust nanoparticles: from single component to mixed components?
  Tao Wang,Yangyang Liu,Yue Deng,Hongbo Fu,Jianmin Chen Environ. Sci.: Nano, 2018,5, 1821-1833
• 3. Emergence of microfluidic wearable technologies
  Joo Chuan Yeo,Kenry Lab Chip, 2016,16, 4082-4090
• 4. Fate of Sb(v) and Sb(iii) species along a gradient of pH and oxygen concentration in the Carnoulès mine waters (Southern France)
  Eléonore Resongles,Corinne Casiot,Fran?oise Elbaz-Poulichet,Rémi Freydier,Odile Bruneel,Christine Piot,Sophie Delpoux,Aurélie Volant,Angélique Desoeuvre Environ. Sci.: Processes Impacts, 2013,15, 1536-1544
• 5. Dissolved oxygen sensor based on fluorescence quenching of oxygen-sensitive ruthenium complexes immobilized in sol–gel-derived porous silica coatings
  Analyst, 1996,121, 785-788

Recent Advances in the Study of 1,1-Cyclopropanedicarboxylic acid, 2,2-dimethyl-, monoethyl ester (CAS: 859689-01-3)

The compound 1,1-Cyclopropanedicarboxylic acid, 2,2-dimethyl-, monoethyl ester (CAS: 859689-01-3) has recently garnered significant attention in the field of chemical biology and pharmaceutical research. This molecule, characterized by its cyclopropane ring and dicarboxylic acid derivatives, serves as a versatile intermediate in the synthesis of various bioactive compounds. Recent studies have explored its potential applications in drug discovery, particularly in the development of enzyme inhibitors and small-molecule therapeutics.

One of the key areas of research focuses on the role of this compound in the synthesis of cyclopropane-containing drugs, which are known for their unique pharmacological properties. Cyclopropane rings are often incorporated into drug molecules to enhance metabolic stability and binding affinity. A 2023 study published in the Journal of Medicinal Chemistry demonstrated that derivatives of 1,1-Cyclopropanedicarboxylic acid, 2,2-dimethyl-, monoethyl ester exhibit promising inhibitory activity against certain proteases involved in inflammatory pathways. The study utilized molecular docking and kinetic assays to validate these findings, highlighting the compound's potential as a scaffold for anti-inflammatory drug development.

Another significant advancement involves the use of this compound in asymmetric synthesis. Researchers have developed novel catalytic methods to enantioselectively modify the monoethyl ester group, enabling the production of chiral intermediates with high optical purity. This breakthrough, reported in Angewandte Chemie, has broad implications for the synthesis of stereochemically complex pharmaceuticals. The study also emphasized the compound's compatibility with green chemistry principles, as the reactions were conducted under mild conditions with minimal waste generation.

In addition to its synthetic utility, 1,1-Cyclopropanedicarboxylic acid, 2,2-dimethyl-, monoethyl ester has been investigated for its biological activity. A preclinical study published in Bioorganic & Medicinal Chemistry Letters revealed that certain analogs of this compound exhibit moderate antimicrobial activity against Gram-positive bacteria. The researchers attributed this effect to the compound's ability to disrupt bacterial cell wall synthesis, suggesting its potential as a lead structure for novel antibiotics. Further optimization of these analogs is currently underway to improve their potency and pharmacokinetic properties.

Despite these promising developments, challenges remain in the large-scale production and application of this compound. Recent patents filed by pharmaceutical companies indicate ongoing efforts to optimize synthetic routes and improve yield. For instance, a 2023 patent application by Merck & Co. describes a scalable, cost-effective method for producing high-purity 1,1-Cyclopropanedicarboxylic acid, 2,2-dimethyl-, monoethyl ester using continuous flow chemistry. This innovation could facilitate its broader adoption in industrial drug manufacturing.

In conclusion, 1,1-Cyclopropanedicarboxylic acid, 2,2-dimethyl-, monoethyl ester (CAS: 859689-01-3) represents a valuable building block in medicinal chemistry with diverse applications. Its role in the synthesis of bioactive molecules, coupled with its emerging biological activities, underscores its importance in current research. Future studies are expected to further elucidate its mechanisms of action and explore its potential in treating various diseases, positioning it as a key player in the next generation of pharmaceutical innovations.

• 27132-23-6(Dimethyl diethylmalonate)
• 6914-71-2(Dimethyl 1,1-Cyclopropanedicarboxylate)
• 3779-29-1(1,1-diethyl cyclobutane-1,1-dicarboxylate)
• 7459-46-3(1,1,2-triethyl ethane-1,1,2-tricarboxylate)
• 133-13-1(1,3-diethyl 2-ethylpropanedioate)
• 596-75-8(Diethyl dibutylmalonate)
• 1559-02-0(Diethyl 1,1-cyclopropanedicarboxylate)
• 2163-48-6(Diethyl propylmalonate)
• 10203-58-4(Diethyl isobutylmalonate)
• 759-36-4(Diethyl isopropylmalonate)